Pablo García Jaén: rFVIIa Shows Promise for Secondary Prophylaxis in Glanzmann Thrombasthenia
Pablo García Jaén, Specialist in Hematology and Hemotherapy at Salamanca University Healthcare Complex (CAUSA), shared on LinkedIn about a recent article he and his colleagues co-authored, published in RPTH, adding:
”Very pleased to share our recently published Brief Report in Research and Practice in Thrombosis and Haemostasis:
‘Efficacy and safety of recombinant activated factor VII for secondary prophylaxis in patients with Glanzmann thrombasthenia’
In this multicenter Spanish study, we describe the use of rFVIIa as secondary prophylaxis in patients with Glanzmann thrombasthenia and recurrent severe bleeding despite standard therapy.
We are proud to contribute to the limited evidence in this rare inherited platelet disorder and to share the first Spanish Brief Report focused on this field.
Many thanks to all participating centers, colleagues, patients and families, as well as GEAPC, RETPLAC and SETH, for making this collaborative work possible.”
Title: Efficacy and safety of recombinant activated factor VII for secondary prophylaxis in patients with Glanzmann thrombasthenia
Authors: Pablo García-Jaén, Nuria Fernández-Mosteirin, María Luisa Serrano, Susana Riesco, Carlos Aguilar, David Gabaldon, Sara Kanaan-Leis, Almudena González-Prieto, Raquel Portugal, María Carmen Mendoza, Carmen Gilabert, Ana Hortal, Lorena Díaz-Ajenjo, Ana Lama-Villanueva, Alba Mei González-Galán, Ana Sánchez-Fuentes, Rocío Benito, José Rivera, José Ramón González-Porras, José María Bastida
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 1, 2026, 15:44A Century of Von Willebrand Disease Awareness – EHC
-
Oct 1, 2026, 15:31Andreas Calatzis: The Power of Teamwork in Postpartum Hemorrhage
-
Oct 1, 2026, 15:09Halimat Olaniyan: The Role of Transfusion Medicine in Sickle Cell Disease Care
-
Oct 1, 2026, 14:58Samir Kumar Beura: Modern Approaches to Platelet Structure and Function
-
Oct 1, 2026, 14:39Understanding the FDA Pathway for Hematology Product Development – American Society of Hematology
-
Oct 1, 2026, 13:56Ravi C Dara: Advancing Red Cell Exchange in Sickle Cell Disease
-
Oct 1, 2026, 13:50Mateo Marin-Cuartas: What Matters After Aortic Valve Replacement in Younger Patients?
-
Oct 1, 2026, 13:17Anirban Sen Gupta: Sharing Ideas, Advancing Biomedical Innovation
-
Oct 1, 2026, 13:01Michael Honigberg: Clonal Hematopoiesis as a Driver of Aortic Valve Calcification